Clinical Trials Browser

Interventional × Recurrence × Axitinib × Clear all

NCT04562441 2025-01-10

NPC - AXEL Study : Axitinib-Avelumab

Phase 2 Completed

Recurrence

NCT01562197 2019-01-24

AxiGII

Phase 2 Completed

Glioblastoma, Recurrence

NCT01558661 2017-11-28

Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma

Phase 2 Completed

33 enrolled 10 charts

Carcinoma, Adenoid Cystic, Neoplasm Metastasis, Recurrence